Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicole Rojas-Colonelli"'
Autor:
Camila Flores, Felipe Gálvez-Cancino, Cesar Oyarce, Manuel Varas-Godoy, Paola Murgas, Sebastián Cruz-Gómez, Nicole Rojas-Colonelli, Daniela Sauma, Alvaro Lladser, Jonathan A. Roco
Publikováno v:
Vaccine. 35:4148-4154
DNA vaccination is an attractive approach to elicit tumor-specific cytotoxic CD8+ T lymphocytes (CTL), which can mediate protective immunity against tumors. To initiate CTL responses, antigen-encoding plasmids employed for DNA vaccination need to act
Autor:
María Carmen Molina, Octavio Aravena, Corina Peña, David Gárate, Carolina H. Ribeiro, Diego Catalán, Nicole Rojas-Colonelli, Paula Abello, Lorena Salazar, Barbara Pesce, Paulina A García-González, Juan Carlos Aguillón
Publikováno v:
ARTHRITIS AND RHEUMATISM
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Objective Dendritic cells (DCs) modulated with lipopolysaccharide (LPS) are able to reduce inflammation when therapeutically administered into mice with collagen-induced arthritis (CIA). The aim of this study was to uncover the mechanisms that define
Autor:
Paula Abello, Juan Carlos Aguillón, René E. M. Toes, Octavio Aravena, Lorena Salazar, Barbara Pesce, Diego Catalán, Miguel Cuchacovich, Nicole Rojas-Colonelli, María Carmen Molina, Carlos González, Flavio Salazar-Onfray, Adam Aguirre, Mario Delgado, Juan Contreras-Levicoy, Raquel Cepeda, Roberto Zúñiga, Alejandro Escobar
Publikováno v:
ANNALS OF THE RHEUMATIC DISEASES
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Background: The use of regulatory or immature dendritic cells (DCs) as tools for modulating experimental rheumatoid arthritis is very recent. Tumour necrosis factor (TNF)-stimulated DCs have been shown to restore tolerance in experimental autoimmune
Publikováno v:
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
DNA vaccines have been shown to elicit tumor-protective cytotoxic T lymphocyte (CTL) immunity in preclinical models, but have shown limited efficacy in cancer patients. Plasmids used for DNA vaccines can stimulate several innate immune receptors, tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33dabeb68ec82680ab0af286cfe507fc
https://europepmc.org/articles/PMC3906403/
https://europepmc.org/articles/PMC3906403/
Autor:
Maarten A. Ligtenberg, Alvaro Lladser, Nicole Rojas-Colonelli, Jonathan A. Roco, Andrés A. Herrada, Paula Gonzalez-Figueroa, Cesar Oyarce
Publikováno v:
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
DNA vaccines have emerged as an attractive strategy to promote protective cellular and humoral immunity against the encoded antigen. DNA vaccines are easy to generate, inexpensive to produce and purify at large-scale, highly stable and safe. In addit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4bee9927b8fd3fdfc998703942a9fd
Autor:
M.I. Peña, Juan Carlos Aguillón, Diego Catalán, David Gárate, Nicole Rojas-Colonelli, Octavio Aravena
Publikováno v:
CLINICAL IMMUNOLOGY
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT